CClinicalTrials.gg
RecruitingNCT05299138REACHUpdated Feb 27, 2025

Restoring Empowerment and Choosing Hope (REACH)

An interventional study of Marriage and Relationship Enhancement Skills (MRES) Intervention in Intervention and Wait List Control, sponsored by Jewish Family & Children's Service of the Suncoast, Inc.. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-27.

Sponsored by Jewish Family & Children's Service of the Suncoast, Inc. · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Feb 2022; still recruiting 4 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
900
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goals of REACH are to help adults develop the skills they need to develop healthy relationship and marriage skills, improve ability to parent and co-parent effectively, identify and enhance skills and abilities required to gain or retain economic self-sufficiency, and foster family stability and increase successful marriage rates. Data from the tri-county region comprised of Sarasota, Manatee, and Charlotte counties demonstrates the presence of a number of risk factors affecting family stability, including high rates of single-parent households, births to unwed mothers, and high median rent costs compared to poverty rates and income. By providing families with relationship enhancement, parenting, and economic self-sufficiency services, this should help to optimize each family member's quality of life and improve child well-being.

Read the detailed description

REACH will serve a minimum of 337 individual adults during each full year of the five-year grant term in Sarasota, Manatee, and Charlotte counties on the Gulf Coast of Florida. REACH will target individual participants and, in cases where both members of a couple are interested in participating, will deliver services to each partner individually. The primary target population for REACH is low-income, at-risk individuals.

Coupled with its successful history of providing healthy marriage programming, JFCS is well-positioned to help families in crisis become more stable and self-sufficient. Understanding the inextricable link between financial security and family stability, REACH is targeting and reaching the most vulnerable individuals based solely on economic risk factors. REACH will incorporate a comprehensive employment program combining both job and career advancement. This will help families in crisis reach improved financial stability, which will in turn improve the ability of individual participants to be better parents and better partners, furthering the goal of promoting healthy marriages and reducing local divorce rates.

02

Conditions studied

  • Intervention
  • Wait List Control

Keywords

  • Healthy relationships, economic self-sufficiency
03

In context

Lead sponsor

Jewish Family & Children's Service of the Suncoast, Inc. is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • adults age 18 or older
  • interested in education about strengthening their current marriage or committed relationship
  • reside in Sarasota, Manatee, and Charlotte counties on the Gulf Coast of Florida

Exclusion criteria

Exclusion Criteria:

  • under age 18
  • do not reside in Sarasota, Manatee, and Charlotte counties
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
900 participants (estimated)

Study arms

  • Experimental
    Marriage and Relationship Enhancement Skills (MRES) Intervention

    The Intervention group will be assigned a Case Manager and begin Marriage and Relationship Enhancement Skills (MRES) class weekly and meet with their Case Manager as needed.

    Behavioral: Marriage and Relationship Enhancement Skills (MRES) Intervention

  • No intervention
    Wait list control

    The Control group will be placed on a wait-list and offered services as soon as they complete the study's final 22-week follow-up measures. Control participants will not be assigned a Case Manager and will not receive any comparable services from our agency until they complete their 22-week measures.

Interventions

  • BehavioralMarriage and Relationship Enhancement Skills (MRES) Intervention

    The Intervention group will be assigned a Case Manager and placed in the next available Marriage and Relationship Enhancement Skills (MRES) class that is convenient for their schedule. Intervention participants will attend classes weekly and meet with their Case Manager weekly, bi-weekly, or monthly, as needed. Study measures will be gathered from intervention participants at baseline, 10 weeks after baseline, and then 22 weeks after baseline. The following tools will be utilized at baseline and follow-up assessment: (1) REACH program eligibility screening (only conducted at baseline), (2) Information, Family Outcomes, Reporting, and Management (nFORM) system, (3) Family Environment Scale (FES), (4) Revised Dyadic Adjustment Scale (RDAS), and (5) Economic Self-Sufficiency Scale (ESS).

06

What researchers measure

Primary outcomes

  1. Family Environment Survey (FES)

    The FES was developed to measure social and environmental characteristics of families. Face and content validity are supported by clear statements about family situations that relate to subscale domains, and the measure can differentiate between distressed and normal family samples.

    Time frame: 22 weeks after baseline

Secondary outcomes

  1. Revised Dyadic Adjustment Scale (RDAS)

    The RDAS is a 32-item self-report standardized measure with 4 subscales (Dyadic Consensus, Dyadic Satisfaction, Affectional Expression, Dyadic Cohesion) in addition to a total score.

    Time frame: 22 weeks after baseline

Other outcomes

  1. Economic Self-Sufficiency Scale (ESS)

    The ESS includes the following subscales with demonstrated reliability and validity: 1) Financial Management Attitudes Scale, 2) Scale of Economic Self-Sufficiency, 3) Financial Knowledge Scale, 4) Family Empowerment Scale, and 5) Financial Management and Planning Behaviors.

    Time frame: 22 weeks after baseline

07

Study locations

1 of 1 sites recruiting
  • Jewish Family and Children Service
    Sarasota, Florida 34237, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05299138
Lead sponsor
Jewish Family & Children's Service of the Suncoast, Inc.
Responsible party
Sponsor
First posted
Mar 28, 2022
Start date
Feb 17, 2022
Primary completion
Jun 1, 2025 (estimated)
Completion
Jun 1, 2025 (estimated)
Last update
Feb 27, 2025

Study contacts

Andrew Truman, BS
Contact
atruman@jfcs-cares.org
9412564130
Kathleen A Moore, PhD
Contact
katkeeley1122@gmail.com
813-485-6977
Katelyn Kopakin, MA
study director · Jewish Family Children's Services of the Suncoast, Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion